Cardicell

Company Overview

Snapshot

Founded in January 2006 by Lior Berkner, Cardicell operates with 1–10 employees. The company is currently in the Pre-Funding stage.

Business overview

Cardicell is developing a self-care medical device in the cardiac tele-medicine field, focusing on detecting life-threatening diseases. Its core technology utilizes a signal-acquisition method for wireless detection of cardiac abnormalities, enabling prompt analysis of heart attacks through a tiny personal device. This device is designed for use by the general population for preliminary diagnosis of chest pains, requiring no prior medical knowledge. Cardicell operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices and diagnostics devices markets.

Company Intelligence Q&A

What is Cardicell's primary focus?

Cardicell is focused on developing a self-care medical device for cardiac tele-medicine, specifically designed for the detection and preliminary diagnosis of heart attacks.

When was Cardicell founded?

Cardicell was founded in January 2006.

Who founded Cardicell?

Cardicell was founded by Lior Berkner, who also serves as the CEO.

What technology does Cardicell utilize?

Cardicell's core technology involves a signal-acquisition method that enables wireless detection of cardiac abnormalities through a user-friendly interface.

What is the current status of Cardicell?

Cardicell is currently in a Non Active status as of November 2016, and is in the Pre-Funding stage.